肿瘤学与转化医学（英文）2022，Vol.8Issue(6)：301-310,10.DOI:10.1007/s10330-022-0605-5
Treatment-related adverse events of combined anti-angiogenic and immune checkpoint inhibitors: systematic review and meta-analysis
Treatment-related adverse events of combined anti-angiogenic and immune checkpoint inhibitors: systematic review and meta-analysis
Lian Chen 1Ling Wu 2Zhang Lu 1Qin Huang 1Liu Huang1
作者信息
- 1. Department of Oncology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
- 2. Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
- 折叠
摘要
关键词
combination therapy/immune checkpoint inhibitor/angiogenesis inhibitor/treatment-related adverse events/systematic review/meta-analysisKey words
combination therapy/immune checkpoint inhibitor/angiogenesis inhibitor/treatment-related adverse events/systematic review/meta-analysis引用本文复制引用
Lian Chen,Ling Wu,Zhang Lu,Qin Huang,Liu Huang..Treatment-related adverse events of combined anti-angiogenic and immune checkpoint inhibitors: systematic review and meta-analysis[J].肿瘤学与转化医学（英文）,2022,8(6):301-310,10.
